The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 04, 2024
Filed:
Mar. 01, 2022
Applicant:
Stealth Biotherapeutics Inc., Needham, MA (US);
Inventor:
D. Travis Wilson, Newton, MA (US);
Assignee:
STEALTH BIOTHERAPEUTICS INC., Needham, MA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/07 (2006.01); A61K 31/137 (2006.01); A61K 31/185 (2006.01); A61K 31/337 (2006.01); A61K 31/366 (2006.01); A61K 31/4245 (2006.01); A61K 31/4748 (2006.01); A61K 31/55 (2006.01); A61K 31/7042 (2006.01); A61K 33/243 (2019.01); A61K 38/08 (2019.01); A61P 25/02 (2006.01);
U.S. Cl.
CPC ...
A61K 38/07 (2013.01); A61K 31/137 (2013.01); A61K 31/185 (2013.01); A61K 31/337 (2013.01); A61K 31/366 (2013.01); A61K 31/4245 (2013.01); A61K 31/4748 (2013.01); A61K 31/55 (2013.01); A61K 31/7042 (2013.01); A61K 33/243 (2019.01); A61K 38/08 (2013.01); A61P 25/02 (2018.01);
Abstract
The disclosure relates to methods for treating a subject suffering from hyperalgesia caused by drug-induced neuropathy by administering to the subject an effective amount of an aromatic-cationic peptide. The disclosure also relates to methods for protecting a subject from hyperalgesia caused by drug-induced neuropathy by administering an effective amount of an aromatic-cationic peptide to a subject at risk for developing the condition.